Tiotropium Inhalation Solution

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Pulmonary Disease, Chronic Obstructive

Phase 3

Tiotropium / Respimat One-Year Study

CompletedNCT00168844

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2003-01-31Updated: 2014-05-20

Tiotropium / Respimat One-Year Study

CompletedNCT00168831

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2003-02-28Updated: 2014-05-20

Related Papers

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.

2020-09-1738 citations

Assessing COPD profiles and outcomes by dyspnoea severity

2016-09-012 citations

LATE-BREAKING ABSTRACT: Tiotropium efficacy and exacerbation risk in patients with different blood eosinophil levels

2015-09-014 citations